Rocket Pharmaceuticals (RCKT) Current Assets (2014 - 2026)
Rocket Pharmaceuticals' Current Assets was $289.55 million in Q2 2026, up 4.5% from $277.16 million a year earlier and up 93.3% from the prior quarter.
Rocket Pharmaceuticals (RCKT) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Rocket Pharmaceuticals came in at $192.73 million, down 49.0% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -16.9% (FY2020 to FY2025).
- In earlier years, Current Assets was $378.18 million in FY2024 (unchanged), $378.22 million in FY2023 (+3.9%), $364.06 million in FY2022 (-7.1%) and $392.06 million in FY2021 (-19.6%).
- The Q2 2026 figure marks the highest quarterly Current Assets since Q1 2025.
- Compared with a year earlier, Current Assets was higher in 1 of the last eight quarters, with an average decline of 20.2%.
- The best year-over-year quarter for Current Assets over five years was Q3 2021 (growth of 82.3%); the worst was Q1 2026 (a decline of 53.8%).
- Per Business Quant data, RCKT's Current Assets in the three quarters before Q2 2026 was $149.83 million (Q1 2026), $192.73 million (Q4 2025) and $227.68 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - | 289.55 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 289.55 Mn |
| Mar 31, 2026 | 149.83 Mn |
| Dec 31, 2025 | 192.73 Mn |
| Sep 30, 2025 | 227.68 Mn |
| Jun 30, 2025 | 277.16 Mn |
| Mar 31, 2025 | 324.49 Mn |
| Dec 31, 2024 | 378.18 Mn |
| Sep 30, 2024 | 241.75 Mn |
| Jun 30, 2024 | 292.73 Mn |
| Mar 31, 2024 | 345.16 Mn |
| Dec 31, 2023 | 378.22 Mn |
| Sep 30, 2023 | 446.87 Mn |
| Jun 30, 2023 | 312.07 Mn |
| Mar 31, 2023 | 338.03 Mn |
| Dec 31, 2022 | 364.06 Mn |
| Sep 30, 2022 | 311.13 Mn |
| Jun 30, 2022 | 325.77 Mn |
| Mar 31, 2022 | 353.85 Mn |
| Dec 31, 2021 | 392.06 Mn |
| Sep 30, 2021 | 425.07 Mn |
Rocket Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RCKT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();